Sec. 7261. Policy and briefing on availability of naloxone to treat opioid, including Fentanyl, overdoses
607 words·~3 min read·
/bill/119/s/1071/eah/section-7261A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 1 year after the date of enactment of this Act, the Commandant shall update the policy of the Coast Guard regarding the use of medication to treat drug overdoses, including the use of drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. ) for emergency treatment of known or suspected opioid overdose. The updated policy required under subsection
(a)shall require opioid overdose reversal medications be available— at each Coast Guard clinic; at each independently located Coast Guard unit; onboard each Coast Guard cutter; and for response to known or suspected opioid overdoses, such as fentanyl, at other appropriate Coast Guard installations and facilities and onboard other Coast Guard assets. Not later than 1 year after the earlier of the date of enactment of this Act or the date on which the tracking system established under section 706 of the National Defense Authorization Act for Fiscal Year 2024 ( 10 U.S.C. 1090 note) is established, the Commandant shall ensure the participation of the Coast Guard in the such tracking system. Not later than 1 year after the earlier of the date of enactment of this Act or the date on which the tracking system established under section 706 of the National Defense Authorization Act for Fiscal Year 2024 ( 10 U.S.C. 1090 note) is established, the Secretary of the department in which the Coast Guard is operating when not operating as a service in the Navy and the Secretary of Defense shall finalize a memorandum of understanding to facilitate Coast Guard access such tracking system. Not later than 2 years after the date of enactment of this Act, the Commandant shall provide the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Transportation and Infrastructure of the House of Representatives a briefing on the use, by members and personnel of the Coast Guard at Coast Guard facilities, onboard Coast Guard assets, and during Coast Guard operations, of— opioid overdose reversal medications; and opioids, including fentanyl. The briefing required under paragraph
(1)shall include the following: A description of— the progress made in the implementation of the updated policy required under subsection (a); the prevalence and incidence of the illegal use of fentanyl and other controlled substances in the Coast Guard during the 5-year period preceding the briefing; processes of the Coast Guard to mitigate substance abuse in the Coast Guard, particularly with respect to fentanyl; and the status of the memorandum of understanding required under subsection (d). For the 5-year period preceding the briefing, a review of instances in which naloxone or other similar medication was used to treat opioid, including fentanyl, overdoses at a Coast Guard facility, onboard a Coast Guard asset, or during a Coast Guard operation. In carrying out the requirements of this section, the Commandant shall ensure compliance with all applicable privacy law, including section 552a of title 5, United States Code (commonly referred to as the Privacy Act ), and the privacy regulations promulgated under section 264(c) of the Health Insurance Portability and Accountability Act ( 42 U.S.C. 1320d–2 note). For purposes of the availability requirement under subsection (b), with respect to a Coast Guard installation comprised of multiple Coast Guard facilities or units, opioid overdose reversal medications available at a single Coast Guard facility within the installation shall be considered to be available to all Coast Guard facilities or units on the installation if appropriate arrangements are in place to ensure access, at all times during operations, to the opioid overdose reversal medications contained within such single Coast Guard facility.
Connectionstraces to 2
Traces to 2 documents
1 reference not yet in our index
- 42 USC 1320d–2
Citation graph
cites case law
Sec. 7261
Policy and briefing on availability of naloxone to treat opioid, including Fentanyl, overdoses
Cite42 USC 1320d–2
Cites 3Cited by 0 across 0 sources